[ Price : $8.95]
In a head-to-head trial, Eli Lillys weight-loss drug Zepbound (tirzepatide) shows superiority over Novo Nordisks Wegovy (semagluti...[ Price : $8.95]
FDA awards Stoke Therapeutics a breakthrough therapy designation for zorevunersen and its use in treating Dravet syndrome.[ Price : $8.95]
FDA warns Chinas YouQuan Care Products about CGMP violations in its manufacturing of finished drugs.[ Price : $8.95]
Roivants Kinevant Sciences unit halts the development of namilumab for treating sarcoidosis after a Phase 2 study failed to show t...[ Price : $8.95]
FDA issues a report and plan on best practices for guidances, incorporating comments from a 2023 draft report and plan.[ Price : $8.95]
FDA publishes a guidance with recommendations for marketing submissions for Predetermined Change Control Plans for artificial inte...[ Price : $8.95]
FDA warns South Koreas LCC Ltd. about CGMP violations in its manufacturing of unapproved and misbranded over-the-counter drugs.[ Price : $8.95]
FDA grants Merck a breakthrough therapy designation for sacituzumab tirumotecan (sac-TMT) and its use in treating certain patients...